跳至主要内容
临床试验/NCT00568204
NCT00568204已完成不适用

Proof of Concept of MEXYN-A

Evangelical Synod Medical Centre2 个研究点 分布在 1 个国家目标入组 279 人开始时间: 2002年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
279
试验地点
2
主要终点
Treating Pruritus

研究概览

简要总结

Atomised Methoxymethane-in-Aqua (MEXYN-A) a new topical self-chilled, non-steroidal, non-flammable, pressurised spray which embodies in one simultaneous application, most of the currently recognised and effective chemical, mechanical and thermal anti-pruritic therapies and hydrotherapy.

详细描述

The primary clinical endpoint was to establish MEXYN-A efficacy and safety in abolishing or reducing pruritus related to cutaneous diseases, insect bites and poison ivy, within few seconds of the application. The secondary endpoint was to measure the itch free period as a result of the new intervention.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
5 Years 至 80 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients suffering from severe itching due to : Atopic Dermatitis, contact dermatitis, psoriasis, urticaria, xerosis, prickly heat, genital pruritus, chicken pox, aquagenic pruritus, lichen planus, poison ivey, insect bites.
  • Past experience with the use of at least one conventional medication for pruritus or conventional medication for the same disorder patients suffered.

排除标准

  • Patients who have taken any anti-pruritic drug during the month prior to participation.
  • Patients who have taken drugs for any reason for 2 days prior to participating in the study.

结局指标

主要结局

Treating Pruritus

时间窗: three days

次要结局

  • measuring itch-free period after applying the new treatment, effect on sleep disturbance(three days)

研究者

发起方
Evangelical Synod Medical Centre
申办方类型
Other

研究点 (2)

Loading locations...

相似试验